查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991354

全球生命科學分析市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Life Science Analytics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生命科學分析市場將從 2025 年的 155.3 億美元成長到 2034 年的 310.7 億美元，2026 年至 2034 年的複合年成長率為 8.01%。

全球生命科學分析市場正快速成長，這主要得益於數據分析在藥物研發、醫療保健和生技領域的日益普及。生命科學分析涉及分析複雜的生物和醫學數據，以支援藥物發現、臨床試驗和醫療保健管理中的決策。數位健康數據的日益豐富正在顯著擴大分析技術在生命科學領域的作用。

多種因素促成了這一市場的成長。製藥公司正利用先進的分析技術加速藥物研發並簡化臨床試驗流程。醫療機構也正在採用資料分析來改善患者療效並最佳化治療方案。此外，人工智慧 (AI) 和機器學習的融合也提高了處理大規模生物資料集的能力。

隨著數位轉型在整個醫療產業的推進，生命科學分析市場前景廣闊。資料管理技術的進步和研發投入的增加有望推動創新。隨著各機構越來越依賴數據驅動的洞察，生命科學分析將在塑造醫療保健和生物技術的未來方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球生命科學分析市場：依組件分類

  • 市場分析、洞察與預測
  • 軟體
  • 服務

第5章：全球生命科學分析市場：按類型分類

  • 市場分析、洞察與預測
  • 報告
  • 說明的
  • 預測分析
  • 指示

第6章 全球生命科學分析市場：依應用分類

  • 市場分析、洞察與預測
  • 研究與開發
  • 銷售和行銷支持
  • 監理合規
  • 供應鏈分析
  • 藥物安全監測

第7章 全球生命科學分析市場：以交付方式分類

  • 市場分析、洞察與預測
  • 一經請求
  • 現場

第8章 全球生命科學分析市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫療設備
  • 製藥
  • 生物技術
  • 基因組學
  • 其他

第9章 全球生命科學分析市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Oracle
    • IQVIA
    • SAS Institute Inc
    • Cognizant
    • IBM
    • Accenture
    • Take Solutions Limited
    • Wipro Limited
    • Veradigm
    • Optum
    • Veeva Systems
    • Axtria
    • Komoda Health Inc
    • Elsevier
簡介目錄
Product Code: VMR11213489

The Life Science Analytics Market size is expected to reach USD 31.07 Billion in 2034 from USD 15.53 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The global life science analytics market has grown rapidly due to the increasing use of data analytics in pharmaceutical research, healthcare, and biotechnology. Life science analytics involves analyzing complex biological and healthcare data to support decision-making in drug development, clinical trials, and healthcare management. The growing availability of digital health data has significantly expanded the role of analytics in the life sciences sector.

Several drivers are contributing to the growth of this market. Pharmaceutical companies are using advanced analytics to accelerate drug discovery and improve clinical trial efficiency. Healthcare organizations are also adopting data analytics to enhance patient outcomes and optimize treatment strategies. Additionally, the integration of artificial intelligence and machine learning has improved the ability to process large biological datasets.

The future of the life science analytics market looks promising as digital transformation continues across the healthcare industry. Advances in data management technologies and increased investment in research are expected to drive innovation. As organizations rely more heavily on data-driven insights, life science analytics will play a crucial role in shaping the future of healthcare and biotechnology.

MARKET SEGMENTATION

By Component

  • Software
  • Services

By Type

  • Reporting
  • Descriptive
  • Predictive
  • Prescriptive

By Application

  • Research And Development
  • Sales And Marketing Support
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

By Delivery

  • On-Demand
  • On-Premise

By End Use

  • Medical Devices
  • Pharmaceutical
  • Biotechnology
  • Genomics
  • Others

COMPANIES PROFILED

  • Oracle, IQVIA, SAS Institute Inc, Cognizant, IBM, Accenture, Take Solutions Limited, Wipro Limited, Veradigm, Optum, Veeva Systems, Axtria, Komoda Health Inc, Elsevier
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Reporting Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Descriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Predictive Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Prescriptive Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Research And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Sales And Marketing Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Regulatory Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Supply Chain Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY DELIVERY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Delivery
  • 7.2. On-Demand Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LIFE SCIENCE ANALYTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Component
    • 9.2.2 By Type
    • 9.2.3 By Application
    • 9.2.4 By Delivery
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Component
    • 9.3.2 By Type
    • 9.3.3 By Application
    • 9.3.4 By Delivery
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Component
    • 9.4.2 By Type
    • 9.4.3 By Application
    • 9.4.4 By Delivery
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Component
    • 9.5.2 By Type
    • 9.5.3 By Application
    • 9.5.4 By Delivery
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Component
    • 9.6.2 By Type
    • 9.6.3 By Application
    • 9.6.4 By Delivery
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LIFE SCIENCE ANALYTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Oracle
    • 11.2.2 IQVIA
    • 11.2.3 SAS Institute Inc
    • 11.2.4 Cognizant
    • 11.2.5 IBM
    • 11.2.6 Accenture
    • 11.2.7 Take Solutions Limited
    • 11.2.8 Wipro Limited
    • 11.2.9 Veradigm
    • 11.2.10 Optum
    • 11.2.11 Veeva Systems
    • 11.2.12 Axtria
    • 11.2.13 Komoda Health Inc
    • 11.2.14 Elsevier